These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 16685399
1. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways. Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H. Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399 [Abstract] [Full Text] [Related]
2. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539 [Abstract] [Full Text] [Related]
3. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP. Cancer Res; 2006 Mar 15; 66(6):3222-9. PubMed ID: 16540674 [Abstract] [Full Text] [Related]
4. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL, Lin JK. Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333 [Abstract] [Full Text] [Related]
5. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ. Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029 [Abstract] [Full Text] [Related]
6. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A. Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422 [Abstract] [Full Text] [Related]
7. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503 [Abstract] [Full Text] [Related]
8. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP. Cancer Res; 2007 Feb 15; 67(4):1636-44. PubMed ID: 17308104 [Abstract] [Full Text] [Related]
9. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Int J Oncol; 2007 Oct 15; 31(4):959-67. PubMed ID: 17786330 [Abstract] [Full Text] [Related]
10. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q, Titus MA, Fung KM, Lin HK. J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593 [Abstract] [Full Text] [Related]
14. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Kim J, Park H, Im JY, Choi WS, Kim HS. Anticancer Res; 2007 Mar 01; 27(5A):3285-92. PubMed ID: 17970072 [Abstract] [Full Text] [Related]
15. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Yu S, Wang X, Ng CF, Chen S, Chan FL. Cancer Res; 2007 May 15; 67(10):4904-14. PubMed ID: 17510420 [Abstract] [Full Text] [Related]
16. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Wang LG, Ossowski L, Ferrari AC. Cancer Res; 2001 Oct 15; 61(20):7544-51. PubMed ID: 11606392 [Abstract] [Full Text] [Related]
17. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Fang J, Zhou Q, Shi XL, Jiang BH. Carcinogenesis; 2007 Mar 15; 28(3):713-23. PubMed ID: 17065200 [Abstract] [Full Text] [Related]
18. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC. Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076 [Abstract] [Full Text] [Related]
19. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040 [Abstract] [Full Text] [Related]
20. Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. Way TD, Lee JC, Kuo DH, Fan LL, Huang CH, Lin HY, Shieh PC, Kuo PT, Liao CF, Liu H, Kao JY. J Agric Food Chem; 2010 Mar 24; 58(6):3356-65. PubMed ID: 20166659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]